{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T12:20:08Z","timestamp":1648815608808},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T00:00:00Z","timestamp":1462838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11096-016-0315-4","type":"journal-article","created":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T02:32:32Z","timestamp":1462847552000},"page":"793-796","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Utility of day 8 blood tests on platinum plus vinorelbine regimen"],"prefix":"10.1007","volume":"38","author":[{"given":"Roc\u00edo","family":"V\u00e1zquez-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Diez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santos","family":"Enrech-Frances","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"S\u00e1nchez-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Molina-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,10]]},"reference":[{"key":"315_CR1","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1200\/JCO.2005.03.045","volume":"23","author":"G D\u2019Addario","year":"2005","unstructured":"D\u2019Addario G, Pintilie M, Leighl NB, Feld R, Cerny T, Shepherd FA. Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature. J Clin Oncol. 2005;23:2926\u201336.","journal-title":"J Clin Oncol"},{"key":"315_CR2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/jnci\/djk196","volume":"99","author":"A Ardizzoni","year":"2007","unstructured":"Ardizzoni A, Boni L, Tiseo M, Fossella FV, Schiller JH, Paesmans M, et al. Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst. 2007;99:847\u201357.","journal-title":"J Natl Cancer Inst"},{"key":"315_CR3","first-page":"CD009256","volume":"8","author":"TB Castria","year":"2013","unstructured":"Castria TB, da Silva EMK, Gois AFT, Riera R. Cisplatin versus carboplatin in combination with third generation drugs for advanced non-small cell lung cancer (Review). Cochrane Database Syst Rev. 2013;8:CD009256.","journal-title":"Cochrane Database Syst Rev"},{"key":"315_CR4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.lungcan.2009.07.018","volume":"68","author":"M Provencio","year":"2010","unstructured":"Provencio M, de Las Pe\u00f1as R, Camps C, Artal A, Massuti B, Cobo M, et al. Cisplatin plus vinorelbine as first-line treatment for advanced non-small-cell lung cancer: is a hemogram on day 8 essential? Lung Cancer. 2010;68:415\u20139.","journal-title":"Lung Cancer"},{"key":"315_CR5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12094-012-0989-6","volume":"15","author":"M Provencio","year":"2013","unstructured":"Provencio M, S\u00e1nchez A, Artal A, S\u00e1nchez Torres JM, Garc\u00eda G\u00f3mez R, Constenla M, et al. Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary. Clin Transl Oncol. 2013;15:659\u201364.","journal-title":"Clin Transl Oncol"},{"key":"315_CR6","unstructured":"Cancer Therapy Evaluation Program. National Cancer Institute. Common terminology criteria for adverse events (CTCAE) v.4.0. Data files and related documents. http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/About.html . Accessed June 2015."},{"key":"315_CR7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00408-012-9399-3","volume":"190","author":"WX Qi","year":"2012","unstructured":"Qi WX, Tang LN, He AN, Shen Z, Lin F, Yao Y. Doublet versus single cytotoxic agent as first-line treatment for elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis. Lung. 2012;190:477\u201385.","journal-title":"Lung"},{"key":"315_CR8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.lungcan.2007.03.014","volume":"57","author":"J Jiang","year":"2007","unstructured":"Jiang J, Liang X, Zhou X, Huang R, Chu Z. A meta-analysis of randomized controlled trials comparing carboplatin based to cisplatin-based chemotherapy in advanced non small cell lung cancer. Lung Cancer. 2007;57:348\u201358.","journal-title":"Lung Cancer"},{"key":"315_CR9","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/annonc\/mdn774","volume":"20","author":"EH Tan","year":"2009","unstructured":"Tan EH, Rolski J, Grodzki T, Schneider CP, Gaztemeier U, Zatloukal P, et al. Global Lung Oncology Branco trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small cell lung cancer. Ann Oncol. 2009;20:1249\u201356.","journal-title":"Ann Oncol"},{"key":"315_CR10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10517-007-0185-9","volume":"143","author":"AM Dygai","year":"2007","unstructured":"Dygai AM, Zhdanov VV, Zyuz\u2019kov GN, Udut EV, Simanina EV, Gur\u2019yantseva LA, et al. Mechanisms of regulation of hemopoiesis during experimental cytostatic myelosuppression induced by carboplatin. Bull Exp Biol Med. 2007;143:581\u20134.","journal-title":"Bull Exp Biol Med"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-016-0315-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-016-0315-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-016-0315-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T01:54:55Z","timestamp":1559354095000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-016-0315-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,10]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["315"],"URL":"https:\/\/doi.org\/10.1007\/s11096-016-0315-4","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,10]]}}}